Press Releases

Year-end Report January - December 2011
February 16, 2012 08:30 (CET)
Active Biotech's Prostate Cancer Project TASQ in Phase I Combination Therapy Trial
January 23, 2012 08:30 (CET)
Active Biotech to Present at the JP Morgan 30th Annual Healthcare Conference
January 4, 2012 08:30 (CET)
Active Biotech's election committee appointed
November 10, 2011 16:00 (CET)
Active Biotech AB Interim Report January - September 2011
November 3, 2011 08:30 (CET)
Information regarding Active Biotech's candidate drug laquinimod
November 2, 2011 15:18 (CET)
INVESTIGATIONAL LAQUINIMOD DEMONSTRATES ITS POTENTIAL AS A NEW ORAL TREATMENT FOR RRMS
October 19, 2011 08:30 (CEST)
Active Biotech's Prostate Cancer Project TASQ Featured in Journal of Clinical Oncology
September 20, 2011 08:30 (CEST)
Active Biotech AB Interim Report January - June 2011
August 11, 2011 08:30 (CEST)
RESULTS OF PHASE III BRAVO TRIAL REINFORCE UNIQUE PROFILE OF LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT
August 1, 2011 13:41 (CEST)